TokenPost·
China Approves Eli Lilly’s Orforglipron Weight-Loss Pill
Lilly is the first drugmaker to receive Chinese clearance for a GLP-1 weight-loss pill, giving it an early lead over Novo Nordisk.
More news
- UnchainedFoundation CEO Says Ethereum Foundation Is Launching a Signing App for Passport Prime
- TokenPostECB Economists Build Reddit Gauge Tied to Next-Day S&P 500 Returns
- Crypto BriefingInvestors brace for tighter US monetary policy amid inflation concerns
- Crypto BriefingVenice founder Erik Voorhees warns against government control of AI
- TokenPostUnocoin Flags Unusual Transfers From BitGo Wallet as Probe Begins
- TokenPostOfcom Says £450,000 of 4chan Penalty Was Not a Meta Fine